1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease
- Contribution to journal › Article
-
Mark
The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer's disease spectrum
- Contribution to journal › Article
-
Mark
Polygenic pathways shape white matter vulnerability to Alzheimer’s disease-related pathophysiological changes
- Contribution to journal › Article
-
Mark
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
- Contribution to journal › Article
-
Mark
Recent advances in neuroimaging of Alzheimer's disease and related dementias
- Contribution to journal › Scientific review
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
- Contribution to journal › Article
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma tau biomarkers for biological staging of Alzheimer’s disease
- Contribution to journal › Article
